COVID 19 is the #1 most commonly reported adverse reaction for NIRMATRELVIR AND RITONAVIR, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 22,774 FDA adverse event reports linking NIRMATRELVIR AND RITONAVIR to COVID 19. This represents approximately 20.6% of all 110,406 adverse event reports for this drug.
NIRMATRELVIR AND RITONAVIR has an overall safety score of 75 out of 100. Patients taking NIRMATRELVIR AND RITONAVIR who experience covid 19 should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COVID 1922,774 of 110,406 reports
COVID 19 is a frequently reported adverse event for NIRMATRELVIR AND RITONAVIR, accounting for a significant proportion of all reports.
Other Side Effects of NIRMATRELVIR AND RITONAVIR
In addition to covid 19, the following adverse reactions have been reported for NIRMATRELVIR AND RITONAVIR:
COVID 19 has been reported as an adverse event in 22,774 FDA reports for NIRMATRELVIR AND RITONAVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COVID 19 with NIRMATRELVIR AND RITONAVIR?
COVID 19 accounts for approximately 20.6% of all adverse event reports for NIRMATRELVIR AND RITONAVIR, making it one of the most commonly reported side effect.
What should I do if I experience COVID 19 while taking NIRMATRELVIR AND RITONAVIR?
If you experience covid 19 while taking NIRMATRELVIR AND RITONAVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.